| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
Advice You - Procurement
The range of activities associated with the buying of goods and services to support business operati According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ons is called procurement. When talking about procurement, planning is the first and most important ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in tep in the whole process. Planning involves selecting missions and objectives and the actions to ach lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ieve them; it requires managers to choose among alternative future courses of action. Plans thus pro here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ide a rational approach to preselected objectives. Planning bridges the gap from where we are to wh d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro re we want to go. It makes it possible for things to occur which would not otherwise happen. Althoug ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc h we can never be sure what will happen in the future, and factors beyond our control may interfere easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ith even the best-laid plans, if we don’t plan we are leaving events to chance. And that is quite ri nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ky when talking about business operations. One wrong step and your business is history. Today, most and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ business enterprises engage in strategic planning, although the degree of sophistication and formal ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ty vary considerably. Conceptually, strategic planning is deceptively simple: analyze the current an ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a expected future situation, determine the direction of the firm, and develop the means for achieving dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod the mission. In reality, this is an extremely complex process which demands a systematic approach f cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin r identifying and analyzing factors outside of the organization and matching them with the firm’s ca tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen abilities. Planning is done in an environment of uncertainty. No one can be sure what the business t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel environment will be even next week, let alone several years from now. Therefore, people make assumpt ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ons or forecasts about the anticipated environment. Some of the forecasts become assumptions for oth y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products r plans. To be effective, strategies and policies must be put into practice by means of plans, incr . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de easing in detail until they get down to the nuts-and-bolts details of operations. Tactics, then, are elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip the actions through which strategies are executed. Strategies must be supported by effective tactics tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Acquisition Of Sears And Kmart Credit Counseling - Another Way Out Maximize Your New Startup Restaurant Sales!
|